Cellular mechanisms of tumour suppression by the retinoblastoma gene

Cited by (975)

Items 601–700 of 975

1. SUMOylation regulates Rb hyperphosphorylation and inactivation in uveal melanoma
   Fengxi Meng, Yiqun Yuan, Hui Ren, Han Yue, Binbin Xu, Jiang Qian · 2021 · Cancer Science
2. The effect of medicarpin on PTEN/AKT signal pathway in head and neck squamous cell carcinoma
   Aysel Kalaycı Yiğin, Hüseyin Dönmez, Mustafa Hitit, Sena Seven, Nadire Eser, Ercan Kurar, Mehmet Seven · 2021 · Journal of Cancer Research and Therapeutics
3. Global serum profiling: an opportunity for earlier cancer detection
   Alexandra Sala, James M. Cameron, Paul Martin Brennan, Emma Jayne Crosbie, Tom Curran, Ewan Gray, Pierre L. Martin‐Hirsch, David Scott Palmer, Ihtesham Ur Rehman, Nicholas J. W. Rattray et al. · 2023 · Journal of Experimental & Clinical Cancer Research
4. Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells
   Rossana Colla Soletti, Deborah Biasoli, Nathassya Accioly Lins Vidal Rodrigues, João Marcos de Azevedo Delou, Renata de Moraes Maciel, Vera Lúcia Antunes Chagas, Rodrigo A. P. Martins, Stevens Kastrup Rehen, Helena L. Borges · 2017 · Translational Oncology
5. CDK4/6 inhibitors in advanced breast cancer, what is beyond?
   Amrallah A. Mohammed, Hanaa Rashied, Fifi Mostafa Elsayed · 2019 · Oncology Reviews
6. Yorkie drives Ras-induced tumor progression by microRNA-mediated inhibition of cellular senescence
   Takao Ito, Tatsushi Igaki · 2021 · Science Signaling
7. Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Clear Cell Renal Cell Carcinoma
   Chong-guo Zhang, Yong-Xing Cui, Guan-Nan Wang, Wu-Gan Zhao, Haiyu Zhao, Xue-song Huang, Min Zhang, Wen-Cai Li · 2021 · Journal of Healthcare Engineering · Retracted
8. Daintain/AIF-1 accelerates the activation of insulin-like growth factor-1 receptor signaling pathway in HepG2 cells
   Shaohui Jia, Zhongxia Du, Hua Jiang, XINGYUAN HUANG, Zhengwang Chen, Ning Chen · 2015 · Oncology Reports
9. Novel retinoblastoma mutation abrogating the interaction to E 2 F 2/3, but not E 2 F 1, led to selective suppression of thyroid tumors
   Hideaki Toki, Maki Inoue, Osamu Minowa, Hiromi Motegi, Yuriko Saiki, Shigeharu Wakana, Hiroshi Masuya, Yoichi Gondo, Toshihiko Shiroishi, Ryoji Yao et al. · 2014 · Cancer Science
10. Human Retinoblastoma Binding Protein 9, a Serine Hydrolase Implicated in Pancreatic Cancers
    Sergey M. Vorobiev, Yuanpeng Janet Huang, J. Seetharaman, Rong Xiao, Thomas Acton, Gaetano Thomas Montelione, Liang Tong · 2012 · Protein and Peptide Letters
11. Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas
    Guoyan Liu · 2010 · World Journal of Gastroenterology
12. Inactivation of INK4a and ARF induces myocardial proliferation and improves cardiac repair following ischemia-reperfusion
    Songtao An, Yan Chen, Chuanyu Gao, Bingyu Qin, Xianhui Du, Fanmin Meng, Yanyan Qi · 2015 · Molecular Medicine Reports
13. Secondary Craniofacial Sarcomas Following Retinoblastoma: A Systematic Review
    Ryuya Yamanaka, Azusa Hayano · 2017 · World Neurosurgery
14. E2F is involved in radioresistance of carbon ion induced apoptosis via Bax/caspase 3 signal pathway in human hepatoma cell
    Yi Xie, Jing Si, Yu‐Pei Wang, Hongyan Li, Cuixia Di, Junfang Yan, Yancheng Ye, Yanshan Zhang, Hong Zhang · 2017 · Journal of Cellular Physiology
15. Rb is required for retinal angiogenesis and lamination
    Yi Zhou, Ran Wei, Liu Zhang, Yongjiang Chen, Suying Lü, Liang Chen, Yujiao Wang, Lirong Xiao, Junjun Zhang, Rod Bremner et al. · 2018 · Cell Death and Disease
16. Phenotype-Independent Effects of Retroviral Transduction in Human Dental Pulp Stem Cells
    Obi Egbuniwe, Andrew D. Grant, Tara F. Renton, Lucy Di Silvio · 2013 · Macromolecular Bioscience
17. Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?
    Ana Amiama-Roig, Laura Pérez‐Martínez, Pilar Rodríguez Ledo, Eva M. Verdugo‐Sivianes, José Ramón Blanco · 2023 · Microorganisms
18. BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint Blockade
    Brian M. Olson, Kiranj Kishor Chaudagar, Riyue Bao, Sweta Sharma Saha, Christina Hong, Marguerite Li, Srikrishnan Rameshbabu, Raymond Chen, Alison Thomas, Akash Patnaik · 2023 · Molecular Cancer Therapeutics
19. Decoding the evolution of dumbbell stomata: Insights from the developmental genes of sedges and grasses
    Alison Pelri Albuquerque Menezes, Emilio Petrone‐Mendoza, James Clark, Salvatore Cozzolino · 2025 · Plant Gene
20. Regulation of cell polarity determinants by the Retinoblastoma tumor suppressor protein
    Sandhya Payankaulam, Kelvin Yeung, Helen McNeill, R. William Henry, David N. Arnosti · 2016 · Scientific Reports
21. Cyclin-Dependent Kinase 4 and 6 Inhibitors: A Quantum Leap in the Treatment of Advanced Breast Cancers
    Sanjana Reddy, Zineb Barkhane, Jalal Elmadi, Lakshmi Satish Kumar, Lakshmi Sree Pugalenthi, Mahlika Ahmad · 2022 · Cureus
22. The role of EZH2 as a potential therapeutic target in retinoblastoma
    Yuqing Zhao, Ying Cheng, Yi Qu · 2023 · Experimental Eye Research
23. Guidance for Life, Cell Death, and Colorectal Neoplasia by Netrin Dependence Receptors
    Christian P. Gespach · 2012 · Advances in cancer research
24. Minimum Free Energy Based Evaluation of mRNAs Secondary Structures Constructed by 18 Clinically Significant Exonic Single Nucleotide Polymorphisms (SNPs) and Haplotypes of 5 Missense SNPs of RB1 Gene
    Sarder Nasir Uddin, Apurba Majumder, Khandker Khaldun Islam, Sk Amir Hossain, Palash Kumar Sarker · 2015 · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology
25. Abnormal expression of seven myogenesis-related genes in extraocular muscles of patients with concomitant strabismus
    Yujuan Zhu, Daming Deng, Chongde Long, Guorong Jin, Qingjiong Zhang, Huangxuan Shen · 2012 · Molecular Medicine Reports
26. pVHL acts as a downstream target of E2F1 to suppress E2F1 activity
    Wei Ji, Jing Wang, Wei Zhang, Xing Liu, Gang Ouyang, Wuhan Xiao · 2013 · Biochemical Journal
27. Hunting complex differential gene interaction patterns across molecular contexts
    Mingzhou Joe Song, Yang Zhang, Alexia J. Katzaroff, Bruce A. Edgar, Laura Buttitta · 2014 · Nucleic Acids Research
28. Biomaterial-engineering and neurobiological approaches for regenerating the injured cerebral cortex
    Itsuki Ajioka · 2016 · Regenerative Therapy
29. Reprogramming of Oncogene Expression in Gingival Mesenchymal Stem Cells Following Long-Term Culture In Vitro
    Agnese Gugliandolo, Thangavelu Soundara Rajan, Domenico Scionti, Francesca Diomede, Placido Bramanti, Emanuela Mazzon, Oriana Trubiani · 2017 · Cellular Reprogramming
30. Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro
    Yun-shen Jiao, Lingyu Ding, Ming Chu, Tieshan Wang, Jiarui Kang, Zhao Xiaofan, Huanhuan Li, Xi Chen, Zirui Gao, Likai Gao et al. · 2017 · PLoS ONE
31. Tumor Suppressor Genes
    Yue Cheng · 2012 · InTech eBooks
32. Carcinoma Initiation via Rb Tumor Suppressor Inactivation: A Versatile Approach to Epithelial Subtype-Dependent Cancer Initiation in Diverse Tissues
    Yurong Song, Debra J. Gilbert, T. Norene O’Sullivan, Chunyu Yang, Wenqi Pan, Alisan Fathalizadeh, Lucy Lu, Diana C. Haines, Philip L. Martin, Terry Van Dyke · 2013 · PLoS ONE
33. Aggressive Serous Carcinomas of the Female Reproductive Tract: Cancer-Prone Cell States and Genetic Drivers
    Daryl J. Phuong, Matalin G. Pirtz, Coulter Q. Ralston, Benjamin D. Cosgrove, John C. Schimenti, Andrea Flesken‐Nikitin, Alexander Yu. Nikitin · 2025 · Cancers
34. The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond
    Erik S. Knudsen, Agnieszka Katarzyna Witkiewicz, Sheheryar Kairas Kabraji · 2026 · Nature Reviews Drug Discovery
35. Mathematical modelling of reversible transition between quiescence and proliferation
    Nishtha Pandey, Palakkad Krishnan Unni Vinod · 2018 · PLoS ONE
36. Decursin inhibits EGFR‐ERK1/2 signaling axis in advanced human prostate carcinoma cells
    Tariq A. Bhat, Arpit Dheeraj, Dhanya K. Nambiar, Surya Pratap Singh, Dongsool Yim, Rana Pratap Singh · 2023 · The Prostate
37. Targeting cyclin-dependent kinases in sarcoma treatment: Current perspectives and future directions
    Alessandra Merlini, Valeria Pavese, Giulia Manessi, Martina Rabino, Francesco Tolomeo, Sandra Aliberti, Lorenzo D’Ambrosio, Giovanni Grignani · 2023 · Frontiers in Oncology
38. Serum Metabolomics of Retinoblastoma: Assessing the Differential Serum Metabolic Signatures of Unilateral and Bilateral Patients
    Khushboo Gulati, Radhika Manukonda, Manikyaprabhu Kairamkonda, Swathi Kaliki, Krishna Mohan Poluri · 2023 · ACS Omega
39. p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
    Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, Nuria Del Valle-Del Pino, Alba Díaz-Pizarro, Sonia Mulero‐Navarro, Angel Román-García, José María Carvajal-González · 2024 · Biomedicines
40. Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy
    Georges Gebrael, Nicolas Sayegh, Chadi Hage Chehade, Yeonjung Jo, Arshit Narang, Beverly Chigarira, Nishita Tripathi, Ayana Srivastava, Clara Tandar, Jessica F. Williams et al. · 2025 · Prostate Cancer and Prostatic Diseases
41. Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma
    Mercy Akuma, Minjun Kim, Chenxuan Zhu, Ellis Wiljer, Antoine Gaudreau-Lapierre, Leshan D. Patterson, Lars Egevad, Simon Tanguay, Laura Trinkle‐Mulcahy, William L. Stanford et al. · 2025 · Cell Death and Disease
42. Comparison of Combinatorial Signatures of Global Network Dynamics Generated by Two Classes of ODE Models
    Peter Crawford-Kahrl, Bree Cummins, Tomáš Gedeon · 2019 · SIAM Journal on Applied Dynamical Systems
43. Prolactinoma
    Mary P. Gillam, Mark E. Molitch · 2010 · Elsevier eBooks
44. Growth inhibitory efficacy of the nutritional herb Psoralea corylifolia in a model of triple‑negative breast cancer
    NITIN T. TELANG, Hareesh Babu Bhaskaran Nair, George Y. Wong · 2021 · International Journal of Functional Nutrition
45. Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program
    Amit S. Adhikari, Teresa L. Sullivan, Rhishikesh Bargaje, Lucy Lu, T. Norene O’Sullivan, Yurong Song, Terry Van Dyke · 2022 · Frontiers in Oncology
46. ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
    Song Yi Bae, Hannah E. Bergom, Abderrahman Day, Joseph T. Greene, Zoi E. Sychev, Gabrianne Larson, Eva Corey, Stephen R. Plymate, Tanya S. Freedman, Justin H. Hwang et al. · 2023 · Frontiers in Endocrinology
47. Retinoblastoma family of proteins and chromatin epigenetics: a repetitive story in a few LINEs
    Diego Elias Montoya-Durango, Kenneth S. Ramos · 2011 · BioMolecular Concepts
48. Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer
    NITIN T. TELANG · 2017 · Biomedical Reports
49. Death of a Dogma: Cyclin D Activates Rb by Mono-phosphorylation
    Steven F. Dowdy · 2017 · Current cancer research
50. Evolution of Transcriptional Repressors Impacts Caenorhabditis Vulval Development
    Helen Chamberlin, Ish Jain, Marcos Corchado-Sonera, Leanne H Kelley, Devika Sharanya, Abdulrahman Jama, Romy Pabla, Adriana T. Dawes, Bhagwati Prasad Gupta · 2020 · Molecular Biology and Evolution
51. Cellular Senescence
    Jessica E. Bolden, Scott W. Lowe · 2015 · Elsevier eBooks
52. Current challenges to underpinning the genetic basis for cholangiocarcinoma
    Antonio Cigliano, Xin Chen, Diego Francesco Calvisi · 2021 · Expert Review of Gastroenterology & Hepatology
53. Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View
    Sadegh Rajabi, Catherine Alix‐Panabières, Arshia Sharbatdar Alaei, Raziyeh Abooshahab, Heewa Shakib, Mohammad Reza Ashrafi · 2022 · Cancers
54. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
    Cecilia Pesini, Laura Artal, Jorge Paúl Bernal, Diego Sánchez‐Martínez, Julián Pardo, Ariel Ramírez-Labrada · 2024 · OncoImmunology
55. Evaluating Effects of Hypomorphic Thoc1 Alleles on Embryonic Development in Rb1 Null Mice
    Meenalakshmi Chinnam, Xiaoling Wang, Xiaojing Zhang, David W. Goodrich · 2016 · Molecular and Cellular Biology
56. A novel function for cyclin D1 as a transcriptional role in oncogenesis and tumor development by ChIP-Seq and RNA-Seq
    Yudi Xiong, Yuan Wang, Tianqi Li, Xiaoyan Yu, Yangyang Zeng, Guohui Xiao, Fuxiang Zhou, Yunfeng Zhou · 2021 · Journal of Cancer
57. Cell cycle expression of polarity genes features Rb targeting of Vang
    Sandhya Payankaulam, Stephanie L. Hickey, David N. Arnosti · 2021 · Cells and Development
58. Gastric Cancer and Viruses: A Fine Line between Friend or Foe
    Ahmad Firoz, Hani Mohammed Ali, Suriya Rehman, Irfan Ahmad Rather · 2022 · Vaccines
59. FAK-mediated phosphorylation at Y464 regulates p85β nuclear translocation to promote tumorigenesis of ccRCC by repressing RB1 expression
    Yanhua Zhang, Baoyu He, Dong Zhang, Yifan Zhang, Chengkun Chen, Wenye Zhang, Shiyi Yang, Meilian Yao, Gaoping Cui, Jun Gu et al. · 2023 · Cell Reports
60. Protein Kinase C Epsilon and Genetic Networks in Osteosarcoma Metastasis
    Atta Goudarzi, Nalan Gökgöz, Mona Gill, Dushanthi Pinnaduwage, Daniele Merico, Jay Steven Wunder, Irene Louise Andrulis · 2013 · Cancers
61. Coordination of cell division and differentiation in plants in comparison to animals
    Attila Fehér, Zoltán Magyar · 2015 · Repository of the Academy's Library (Library of the Hungarian Academy of Sciences)
62. The Pharmacological Profile of Cyclin-dependent Kinase (CDK) 4/6 Inhibitors: Clinical Management of Toxicity and Drug Interactions Related to CDK 4/6 Inhibitor-based Treatment in Advanced/Metastatic Breast Cancer
    Tzelepi Vassiliki, Aristeidis Gogadis, Adamidis Christos, Eleni T. Timotheadou · 2019 · Forum of Clinical Oncology
63. Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma
    Ting Gui, Hui Wen Zheng, Ming Liu, Zhengrong Xia, Xunda Ji, Qiufeng Yin, Dengbin Wang, Yuhua Li, Shuxian Chen · 2021 · Quantitative Imaging in Medicine and Surgery
64. Anti-Proliferative and Pro-Apoptotic Effects Of Dipsacus Asperoides in a Cellular Model for Triple-Negative Breast Cancer
    NITIN T. TELANG, Hareesh Babu Bhaskaran Nair, George Wong · 2022 · Archives of Breast Cancer
65. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis
    Simone Pagliarone, Luca Frattone, Valeria Pirocchi, Leonardo Della Salda, Chiara Palmieri · 2016 · Research in Veterinary Science
66. Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma
    Flurina A.M. Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor Andrea Zwimpfer, Nicola S. Meagher, Sián Fereday, Laura Twomey, Kathleen I. Pishas et al. · 2023 · medRxiv
67. Prediction of pathogenic mutations in human transmembrane proteins and their associated diseases via utilizing pre-trained Bio-LLMs
    Lexin Cao, Lijun Quan, Qiufeng Chen, B. X. Zhang, Zhijun Zhang, Liangchen Peng, Junkai Wang, Yelu Jiang, Liangpeng Nie, Geng Li et al. · 2025 · Communications Biology
68. Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities (Review)
    Chunsik Lee, Jong Kyoung Kim · 2022 · Oncology Letters
69. The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases
    Xuan-Bing Liang, Zhi-Cheng Dai, Rong Zou, Ji‐Xin Tang, Cuiwei Yao · 2023 · International Journal of Molecular Sciences
70. Exploring the Potential Role of Phytopharmaceuticals in Alleviating Toxicities of Chemotherapeutic Agents
    Ujwal N. Katolkar, Sanjay Javerilal Surana · 2024 · Current Protein and Peptide Science
71. Mutating RBF Can Enhance Its Pro-Apoptotic Activity and Uncovers a New Role in Tissue Homeostasis
    Cécile Milet, Aurore Rincheval‐Arnold, Angéline Moriéras, Amandine Clavier, Alexandrine Garrigue, Bernard Mignotte, Isabelle Guénal · 2014 · PLoS ONE
72. CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue
    Andrea Estefanía Portales, Ignacio Miguel, María Jimena Rodriguez, Virginia Novaro, Sabrina Eliana Gambaro, Andrés Giovambattista · 2023 · Life Sciences
73. Rb and nucleolin antagonize in controlling human CD34 gene expression
    Edgar Grinstein, Csaba Mahotka, Arndt Borkhardt · 2011 · Cellular Signalling
74. Mathematical Model of Dynamic Protein Interactions Regulating p53 Protein Stability for Tumor Suppression
    Hua Wang, Guang Peng · 2013 · Computational and Mathematical Methods in Medicine
75. The Key Role of E2F in Tumor Suppression through Specific Regulation of Tumor Suppressor Genes in Response to Oncogenic Changes
    Kenta Kurayoshi, Eiko Ozono, Ritsuko Iwanaga, Andrew P. Bradford, Hideyuki Komori, Keigo Araki, Kiyoshi Ohtani · 2018 · InTech eBooks
76. Therapeutic values of chick early amniotic fluid (ceAF) that facilitates wound healing via potentiating a SASP-mediated transient senescence
    Mashaal Ahmad, Yandi Sun, Xueyao Jia, Jingjia Li, Lihong Zhang, Ze Ran Yang, Yindan Lin, Xueyun Zhang, Zara Ahmad Khan, Jin Qian et al. · 2021 · Genes & Diseases
77. Immunosenescence and Senescence Immunosurveillance: One of the Possible Links Explaining the Cancer Incidence in Ageing Population
    Arnaud Augert, David Bernar · 2013 · InTech eBooks
78. Absence of Inhibin Alpha and Retinoblastoma Protein Leads to Early Sertoli Cell Dysfunction
    Roopa L. Nalam, Claudia Andreu‐Vieyra, Martin Matthew Matzuk · 2010 · PLoS ONE
79. Revealing the Anti-Tumor Effect of Artificial miRNA p-27-5p on Human Breast Carcinoma Cell Line T-47D
    Chien-Wei Tseng, Hsuan‐Cheng Huang, Arthur Chun-Chieh Shih, Ya-Ya Chang, Chung-Cheng Hsu, Jen-Yun Chang, Wen‐Hsiung Li, Hsueh‐Fen Juan · 2012 · International Journal of Molecular Sciences
80. Dysfunction of the RB Retinoblastoma Gene in Cancer
    Francesca Pentimalli, Letizia Cito, Antonio Giordano · 2009 · Humana Press eBooks
81. Gene expression analysis of retinoblastoma tissues with clinico-histopathologic correlation
    GeetaK Vemuganti, Murali Mohan Sagar Balla, Rohini M Nair, Imran Khan, Ravi Kiran Reddy Kalathur, Santosh G Honavar, JavedAli Mohammed, Paturu Kondaiah · 2019 · Journal of Radiation and Cancer Research
82. Adverse Outcome Pathway on Cyp2E1 activation leading to liver cancer
    Anna Francina Webster, Iain B. Lambert, Carole Lyn Yauk · 2021 · OECD series on adverse outcome pathways
83. Cancer Development and Progression and the “Hallmarks of Cancer”
    Dennis Mazingi, Kokila Lakhoo · 2025 · Springer eBooks
84. Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives
    Xiaoya Li, Fang Yang, Meijing Wang, Xiaopeng Huang, Xin Zeng, Lu Zhou, Sixue Peng, Jingyi Zhang · 2025 · Frontiers in Pharmacology
85. DREAM interrupted: severing LIN-35-MuvB association in Caenorhabditis elegans impairs DREAM function but not its chromatin localization
    Paul D. Goetsch, Susan Strome · 2022 · Genetics
86. Synthetic lethality in personalized cancer therapy
    Ying Ki Pang, Meng Cheng, Mu Chen, Kaijun Zhao, Yuanyuan Yin, Min Liu, Jing Zhang, Chunlong Zhong · 2022 · Genome Instability & Disease
87. Cancer Development and Progression and the “Hallmarks of Cancer”
    Dennis Mazingi, Kokila Lakhoo · 2023 · Springer eBooks
88. Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors
    Danielle L. Schaal, Akajiugo A. Amucheazi, Sarah C. Jones, Ebubechukwu H. Nkadi, Rona S. Scott · 2024 · Journal of Virology
89. Proteomic Approaches to Unraveling the RB/E2F Regulatory Pathway
    Jone Mitxelena, Nerea Osinalde, Jesus M., Asier Fullaondo, Ana M. · 2012 · InTech eBooks
90. Active transport of RB protein from the nucleus to the cytoplasm as one of the development mechanisms of HER2-positive breast cancer
    Artur Kowalik, Janusz Kopczyński, Elżbieta Wypiórkiewicz, Stanisław S. Góźdź, Ryszard Mężyk, JANUSZ ALEKSANDER SIEDLECKI · 2013 · Polish Journal of Pathology
91. A Strategy for Direct Chemical Activation of the Retinoblastoma Protein
    Cameron R. Pye, Walter M. Bray, Elise R. Brown, Jason R. Burke, R. Scott Lokey, Seth M. Rubin · 2016 · ACS Chemical Biology
92. Genetics of Osteosarcoma
    Junya Toguchida · 2016 · Springer eBooks
93. The hallmarks of cancer and immunology
    Lara Scheherazade Milane · 2021 · Elsevier eBooks
94. Comparative Analysis of Structural Features in SLiMs from Eukaryotes, Bacteria, and Viruses with Importance for Host-Pathogen Interactions
    Heidy Elkhaligy, Christian A Balbin, J. Siltberg-Liberles · 2022 · Pathogens
95. Dual-Capped Helical Interface Mimics
    Tianxiong Mi, Zhe Gao, Zeynep Mituta, Kevin Burgess · 2024 · Journal of the American Chemical Society
96. Identification of microRNA-mRNA regulatory networks and pathways related to retinoblastoma across human and mouse
    Rui Tian · 2020 · International Journal of Ophthalmology
97. Low penetrance hereditary retinoblastoma in a family: what should we consider in the genetic counselling process and follow up?
    César Serrano, Javier Alonso, Gema Gómez‐Mariano, Elena Aguirre, Orland Dı́ez, Neus Gadea, N. Bosch, Judith Balmañà, Begoña Graña · 2011 · Familial Cancer
98. Specific Targets in Sarcoma and Developmental Therapeutics
    David Morgan Thomas, Andrew J. Wagner · 2010 · Journal of the National Comprehensive Cancer Network
99. The INK4a/ARF Locus
    Dawn E. Quelle, Jackson Nteeba, Benjamin W. Darbro · 2015 · Elsevier eBooks
100. Genomic landscape of retinoblastoma
     Víctor M. Villegas, Aaron S. Gold, Andrea C. Wildner, Fiona J. Ehlies, Timothy G. Murray · 2014 · Clinical and Experimental Ophthalmology